Claus Schneider

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Locally Advanced

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Georg W Wurschi, Stefan Knippen, Thomas Ernst, Claus Schneider, Herry Helfritzsch, Henning Mothes, Yves Liebe, Martin Huber, Andrea Wittig
Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort. Current oncology (Toronto, Ont.) 30 (6) (2023)
Georg W Wurschi, Stefan Knippen, Thomas Ernst, Claus Schneider, Herry Helfritzsch, Henning Mothes, Yves Liebe, Martin Huber, Andrea Wittig
Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort. Current oncology (Toronto, Ont.) 30 (6) (2023)
Georg W Wurschi, Stefan Knippen, Thomas Ernst, Claus Schneider, Herry Helfritzsch, Henning Mothes, Yves Liebe, Martin Huber, Andrea Wittig
Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort. Current oncology (Toronto, Ont.) 30 (6) (2023)
Georg W Wurschi, Stefan Knippen, Thomas Ernst, Claus Schneider, Herry Helfritzsch, Henning Mothes, Yves Liebe, Martin Huber, Andrea Wittig
Long-Term Total Neoadjuvant Therapy Leads to Impressive Response Rates in Rectal Cancer: Results of a German Single-Center Cohort. Current oncology (Toronto, Ont.) 30 (6) (2023)